Abstracts (HTML) Autorenliste

Kandabarau, S

Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia

Kappler, R

Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma

Karow, A

Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia

Kater, J

IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations

Kaufmann, MM

A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations

Khalid, D

Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia

Klimiankou, M

New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia

Klusmann, H J-

Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL

Klusmann, J-H

Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
A CRISPR-based platform to model AML progression using primary human cells
Identifying gene targets for drug repurposing to preventing myeloid malignancies
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma

Kock, F

Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)

Koedijk, JB

Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML

Koehler, R

Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy

Koekman, A

Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation

Kolmar, H

Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies

Kooijmans, S

Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation

Kowarz, E

Designing specific chromosomal translocations of the MLL/KMT2A gene
MLL-r fusion transcripts in healthy individuals by induced gene proximity

Krause, K

Genetic landscape of large cell/anaplastic medulloblastoma – more than one disease

Kreyenberg, H

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Krippner-Heidenreich, A

Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation

Krumbholz, M

Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model

Kühn, MWM

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Külp, M

The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL

Kunz, M

Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)